Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an average 12% body weight loss in a Phase 3 trial. The study, involving overweight or obese adults, revealed significant weight reduction and improved cardiovascular markers.
from Times of India https://ift.tt/QWfEymr
via IFTTT
X unblocks Reuters in India: Government steps in, says didn't request takedown
X, the social media platform, restored Reuters' official account in India after it was temporarily withheld due to a "legal demand." The Ministry of Electronics and Information Technology clarified that the Indian government had not requested the action. X explained that content is withheld based on valid legal requests, and they are working to resolve the issue. from Times of India https://ift.tt/7aZWERy via IFTTT
0 Comments